4-(6-Chloro-2-methylpyrimidin-4-yl)morpholine

Catalog No. :
ACRBXV416
CAS No. :
22177-99-7
Molecular Formula :
C9H12ClN3O
Molecular Weight :
213.67

IUPAC Name:4-(6-chloro-2-methylpyrimidin-4-yl)morpholine

4-(6-Chloro-2-methylpyrimidin-4-yl)morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$213.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(6-Chloro-2-methylpyrimidin-4-yl)morpholine
IUPAC Name4-(6-chloro-2-methylpyrimidin-4-yl)morpholine
MDL No.C192130
Molecular FormulaC9H12ClN3O
Molecular Weight213.67
SMILESCC1=NC(Cl)=CC(N2CCOCC2)=N1
InChI KeyUPGDYMACJFZROW-UHFFFAOYSA-N
Synonym4-(6-Chloro-2-methylpyrimidin-4-yl)morpholine | 22177-99-7 | 4-(6-chloro-2-methyl-4-pyrimidinyl)morpholine | Morpholine,4-(6-chloro-2-methyl-4-pyrimidinyl)- | SCHEMBL913131 | DTXSID50604052 | UPGDYMACJFZROW-UHFFFAOYSA-N | XAA17799 | MFCD07782031 | AKOS005073529 | MB-0702 | 2-m
CAS No.22177-99-7
PubChem CID20245571

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRBXV416 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFUEM270 route compound structure diagram
    ACFUEM2701780-26-3 In Stock
  4. Then
  5. ACRBXV416 route product structure diagram
    ACRBXV41622177-99-7 In Stock
Inquiry

2. ACRBXV416 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFUEM270 route compound structure diagram
    ACFUEM2701780-26-3 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACRBXV416 route product structure diagram
    ACRBXV41622177-99-7 In Stock
Inquiry

Comments (0)